AUSTIN, Texas, Sept. 22, 2017 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, today announced that Eric E. Poma, Ph.D., Chief Executive and Chief Scientific Officer, will provide a corporate overview at the Ladenburg Thalmann 2017 Healthcare Conference, and the Cantor Fitzgerald Global Healthcare Conference.

Ladenburg Thalmann Healthcare Conference
Date:               Tuesday, September 26
Time:               1:30pm Eastern Time
Location:         Sofitel Hotel New York, Odeon Ballroom
Webcast:         http://wsw.com/webcast/ladenburg3/mtem/

Cantor Fitzgerald Healthcare Conference
Date:               Wednesday, September 27
Time:               4:35pm Eastern Time
Location:         InterContinental New York Barclay Hotel, Empire Ballroom 2
Webcast:         http://wsw.com/webcast/cantor6/mtem/

About Molecular Templates 
Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases.  For additional information, please visit Molecular Templates’ website at ​www.mtem.com​.

Investor Contact:
Andrew McDonald, Ph.D.
andrew@lifesciadvisors.com
646-597-6987

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.